Cargando…
Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
Irisin, a recently discovered myokine, has been considered a prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin in patients with heart failure (HF), both with preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evalua...
Autores principales: | Silvestrini, Andrea, Bruno, Carmine, Vergani, Edoardo, Venuti, Angela, Favuzzi, Angela Maria Rita, Guidi, Francesco, Nicolotti, Nicola, Meucci, Elisabetta, Mordente, Alvaro, Mancini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338355/ https://www.ncbi.nlm.nih.gov/pubmed/30657767 http://dx.doi.org/10.1371/journal.pone.0210320 |
Ejemplares similares
-
SUN-066 Circulating Irisin and Correlation with Antioxidant Systems in Different Models of Heart Failure
por: Vergani, Edoardo, et al.
Publicado: (2019) -
Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction
por: Bruno, Carmine, et al.
Publicado: (2020) -
Corrigendum to “Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity”
por: Mancini, Antonio, et al.
Publicado: (2020) -
Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity
por: Mancini, Antonio, et al.
Publicado: (2020) -
Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study
por: Mancini, Antonio, et al.
Publicado: (2021)